Alterations in PTPN11 and other RAS-/MAP-Kinase pathway genes define ganglioglioma with adverse clinical outcome and atypic histopathological features https://www.medrxiv.org/content/10.1101/2022.11.20.22282502
Alterations in PTPN11 and other RAS-/MAP-Kinase pathway genes define ganglioglioma with adverse clinical outcome and atypic histopathological features https://www.medrxiv.org/content/10.1101/2022.11.20.22282502